Literature DB >> 30258540

Deciphering Binding Interactions of IL-23R with HDX-MS: Mapping Protein and Macrocyclic Dodecapeptide Ligands.

Cristina Sayago1, Isabel C Gonzalez Valcarcel2, Yuewei Qian2, John Lee2, Jorge Alsina-Fernandez2, Nathan C Fite2, Juan J Carrillo3, Feiyu F Zhang3, Michael J Chalmers2, Jeffrey A Dodge2, Howard Broughton1, Alfonso Espada1.   

Abstract

Molecular characterization of the binding epitope of IL-23R and its cognate cytokine IL-23 is paramount to understand the role in autoimmune diseases and to support the discovery of new inhibitors of this protein-protein interaction. Our results revealed that HDX-MS was able to identify the binding epitope of IL-23R:IL-23, which opened the way to evaluate a peptide macrocycle described in the literature as disrupter of this autoimmune target. Thus, the characterization of the interactions of this chemotype by HDX-MS in combination with computational approaches was achieved. To our knowledge, this is the first reported structural evidence regarding the site where a small compound binds to IL-23R.

Entities:  

Year:  2018        PMID: 30258540      PMCID: PMC6142055          DOI: 10.1021/acsmedchemlett.8b00255

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

1.  A Binding Site on IL-17A for Inhibitory Macrocycles Revealed by Hydrogen/Deuterium Exchange Mass Spectrometry.

Authors:  Alfonso Espada; Howard Broughton; Spencer Jones; Michael J Chalmers; Jeffrey A Dodge
Journal:  J Med Chem       Date:  2016-02-18       Impact factor: 7.446

2.  Improved docking of polypeptides with Glide.

Authors:  Ivan Tubert-Brohman; Woody Sherman; Matt Repasky; Thijs Beuming
Journal:  J Chem Inf Model       Date:  2013-07-10       Impact factor: 4.956

3.  Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis.

Authors:  Jing Li; Hui Wei; Stanley R Krystek; Derek Bond; Ty M Brender; Daniel Cohen; Jena Feiner; Nels Hamacher; Johanna Harshman; Richard Y-C Huang; Susan H Julien; Zheng Lin; Kristina Moore; Luciano Mueller; Claire Noriega; Preeti Sejwal; Paul Sheppard; Brenda Stevens; Guodong Chen; Adrienne A Tymiak; Michael L Gross; Lumelle A Schneeweis
Journal:  Anal Chem       Date:  2017-02-09       Impact factor: 6.986

4.  Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Authors:  Kim Papp; Alice B Gottlieb; Luigi Naldi; David Pariser; Vincent Ho; Kavitha Goyal; Steven Fakharzadeh; Marc Chevrier; Stephen Calabro; Wayne Langholff; Gerald Krueger
Journal:  J Drugs Dermatol       Date:  2015-07       Impact factor: 2.114

5.  Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.

Authors:  K Papp; D Thaçi; K Reich; E Riedl; R G Langley; J G Krueger; A B Gottlieb; H Nakagawa; E P Bowman; A Mehta; Q Li; Y Zhou; R Shames
Journal:  Br J Dermatol       Date:  2015-10-15       Impact factor: 9.302

6.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

7.  Hydrogen/deuterium exchange mass spectrometry and computational modeling reveal a discontinuous epitope of an antibody/TL1A Interaction.

Authors:  Richard Y-C Huang; Stanley R Krystek; Nathan Felix; Robert F Graziano; Mohan Srinivasan; Achal Pashine; Guodong Chen
Journal:  MAbs       Date:  2017-11-14       Impact factor: 5.857

8.  Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.

Authors:  Yehudi Bloch; Laura Bouchareychas; Romain Merceron; Katarzyna Składanowska; Lien Van den Bossche; Sammy Detry; Srinath Govindarajan; Dirk Elewaut; Filomeen Haerynck; Melissa Dullaers; Iannis E Adamopoulos; Savvas N Savvides
Journal:  Immunity       Date:  2017-12-26       Impact factor: 31.745

9.  Non-canonical interleukin 23 receptor complex assembly: p40 protein recruits interleukin 12 receptor β1 via site II and induces p19/interleukin 23 receptor interaction via site III.

Authors:  Jutta Schröder; Jens M Moll; Paul Baran; Joachim Grötzinger; Jürgen Scheller; Doreen M Floss
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

10.  Structural basis of IL-23 antagonism by an Alphabody protein scaffold.

Authors:  Johan Desmet; Kenneth Verstraete; Yehudi Bloch; Eric Lorent; Yurong Wen; Bart Devreese; Karen Vandenbroucke; Stefan Loverix; Thore Hettmann; Sabrina Deroo; Klaartje Somers; Paula Henderikx; Ignace Lasters; Savvas N Savvides
Journal:  Nat Commun       Date:  2014-10-30       Impact factor: 14.919

View more
  6 in total

Review 1.  Research advances in hydrogen-deuterium exchange mass spectrometry for protein epitope mapping.

Authors:  Haofeng Sun; Lingyun Ma; Leyu Wang; Peng Xiao; Hongmei Li; Min Zhou; Dewei Song
Journal:  Anal Bioanal Chem       Date:  2021-01-06       Impact factor: 4.142

2.  Deciphering site 3 interactions of interleukin 12 and interleukin 23 with their cognate murine and human receptors.

Authors:  Alessandra Esch; Anna Masiarz; Sofie Mossner; Jens M Moll; Joachim Grötzinger; Jutta Schröder; Jürgen Scheller; Doreen M Floss
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

Review 3.  The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease.

Authors:  David Bastian; Yongxia Wu; Brian C Betts; Xue-Zhong Yu
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

4.  Integration of phage and yeast display platforms: A reliable and cost effective approach for binning of peptides as displayed on-phage.

Authors:  Priyanka Pandya; Robert O Sayers; Joey P Ting; Shaghayegh Morshedian; Carina Torres; Justine S Cudal; Kai Zhang; Jonathan R Fitchett; Qing Zhang; Feiyu F Zhang; Jing Wang; Jim D Durbin; Juan J Carrillo; Alfonso Espada; Howard Broughton; Yuewei Qian; Sepideh Afshar
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

Review 5.  Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities.

Authors:  Gloria Pastor-Fernández; Isabel R Mariblanca; María N Navarro
Journal:  Cells       Date:  2020-09-07       Impact factor: 6.600

Review 6.  IL-12 and IL-23-Close Relatives with Structural Homologies but Distinct Immunological Functions.

Authors:  Doreen M Floss; Jens M Moll; Jürgen Scheller
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.